Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
|更新时间:2025-05-07
|
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway
增强出版
“The latest research found that gypenoside L can inhibit the occurrence and development of atherosclerosis and ovarian cancer through the EGFR/STAT3/HK2 pathway, providing a new idea for TCM to treat these two diseases together.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 31, Issue 11, Pages: 125-134(2025)
YANG Ying,ZHAO Jiao,SUN Xiaofei,et al.Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):125-134.
YANG Ying,ZHAO Jiao,SUN Xiaofei,et al.Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway[J].Chinese Journal of Experimental Traditional Medical Formulae,2025,31(11):125-134. DOI: 10.13422/j.cnki.syfjx.20250214.
Molecular Mechanism of Treating Different Diseases with Same Treatment of Gypenoside L Affecting Oxidative Damage HUVEC and OVCAR-3 Through EGFR/STAT3/Glycolytic Pathway增强出版